ADR120STSE:3750 +1.53%39 OCF Yield % is -11.20 as of Jun. 24, 2026. GuruFocus rates TSE:3750 with a GF Score™ of 39/100 and a GF Value™ of 円40.77 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 1,418 Biotechnology companies, ADR120S ranks worse than 56.49% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
ADR120S OCF Yield % Related Terms
ADR120S OCF Yield % Historical Data
* Premium members only.
The historical data trend for ADR120S's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3750 vs VRTX, REGN, ALNY: OCF Yield % Comparison
For the Biotechnology subindustry, ADR120S's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ADR120S OCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ADR120S's OCF Yield % distribution charts can be found below:
* The bar in red indicates where ADR120S's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ADR120S (TSE:3750) has a OCF Yield % of -11.20 as of Jun. 24, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on ADR120S and its competitors. According to the industry distribution chart, ADR120S ranks #801 out of 1418 companies in the Biotechnology industry, placing it in the top 56.5%.
Is ADR120S's OCF Yield % too high?
ADR120S's current OCF Yield % is -11.20. Based on the distribution chart, ADR120S ranks #801 out of 1418 companies in the Biotechnology industry, which is below the industry midpoint. Overall, ADR120S has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ADR120S's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, ADR120S ranks #801 out of 1418 companies for OCF Yield %. This places ADR120S in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on ADR120S and its competitors. ADR120S's current OCF Yield % is -11.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ADR120S stock overvalued right now?
Based on GuruFocus' analysis, ADR120S (TSE:3750) is currently considered Significantly Overvalued. The stock's GF Value™ is 円40.77, compared to a current price of 円797.00 — trading 1854.9% above its estimated fair value. The current OCF Yield % is -11.20. ADR120S's overall GF Score™ is 39/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For ADR120S (TSE:3750), the current OCF Yield % is -11.20 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ADR120S (TSE:3750) Overvalued in 2026?
Based on GuruFocus' analysis, ADR120S stock appears to be overvalued.
The current stock price of 円797.00 is trading 1854.9% above its estimated GF Value™ of 円40.77.
GuruFocus considers ADR120S to be Significantly Overvalued.
Key valuation signals for TSE:3750:
OCF Yield %: -11.20
GF Value™: 円40.77 vs. price of 円797.00 (1854.9% above fair value)
No single metric tells the full story. See the TSE:3750 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ADR120S Inc developing a new clinical approach to cell therapy to provide medical care to patients by providing medical care that responds to unmet medical needs based on its regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.
39GF Score
Get the complete analysis for TSE:3750
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3750 has been successfully added to your 
